The Dylag Lab, led by Andrew M. Dylag, MD, FAAP, investigates the mechanisms by which early-life respiratory exposures, such as oxygen and mechanical ventilation, shape lung development and long-term respiratory outcomes in premature infants. The lab integrates bench, computational, and bedside research to improve lung health and reduce the severity of bronchopulmonary dysplasia (BPD).
Andrew M. Dylag, M.D.
Principal Investigator
- Intermittent hypoxemia metrics enhance bronchopulmonary dysplasia severity predictions in extremely low gestational age newborns.; Pediatric research. 2026 Apr 30.
- A Novel Precision-cut lung slice stretch model using removable inflation materials.; bioRxiv : the preprint server for biology. 2026 Feb 03.
- Reducing Opiate and Benzodiazepine Exposure in Preterm Infants on High-Frequency Jet Ventilation.; Pediatrics. 2026 Jan 21.
- Time-Series Machine Learning for Prediction of Bronchopulmonary Dysplasia.; The Journal of pediatrics. 2026 Jan 19.
Contact Us
Dylag Lab
601 Elmwood Avenue
Rochester, NY 14642